Building momentum through the VPAG review
The latest Operational Review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) took place in late December. In this piece, Pinchas Kahtan, ABPI's Head of…
Read the full articleYou might also wanna read
Virtual & Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during May and early June 2026 from the United S
Virtual and Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during February and early March 2026 from the Un
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
From Constitutional Attack to Statutory Combat: The Next Wave of Medicare Drug-Price Litigation
By: Jimmie L. Bullock Background On May 18, 2026, the Supreme Court declined to review six pharmaceutical manufacturers’ challenges to the M
Virtual & Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during April and early May 2026 from the United
Pharma Media in Cannes 2026
Reflections from the leaders shaping the future of healthcare marketing. The post Pharma Media in Cannes 2026 appeared first on solli .
Comments
Sign in to join the conversation.
No comments yet. Be the first.